Vivoryon Therapeutics N.V. (LON:0R3M)
London
· Delayed Price · Currency is GBP · Price in EUR 1.598
-0.030 (-1.84%)
At close: Jun 17, 2025
Vivoryon Therapeutics Market Cap
Vivoryon Therapeutics has a market cap or net worth of 35.56 million as of June 18, 2025. Its market cap has decreased by -38.11% in one year.
Market Cap
35.56M
Enterprise Value
27.64M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.60
Market Cap Chart
Since October 27, 2014, Vivoryon Therapeutics's market cap has decreased from 106.65M to 35.56M, a decrease of -66.66%. That is a compound annual growth rate of -9.80%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 170.36B |
| GSK plc | 61.23B |
| Haleon | 35.62B |
| Smith & Nephew | 9.57B |
| ConvaTec Group | 5.88B |
| Hikma Pharmaceuticals | 4.69B |
| HUTCHMED (China) | 2.15B |
| Genus | 1.30B |